Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Journal of Neuro-Oncology
|
July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation
Akifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
Nuclear Medicine Communications
|
January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
Sally L George, Nadia Falzone, Sarah Chittenden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 7, 2018
SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
Thankamma Ajithkumar, Gail Horan, Laetitia Padovani, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers
Georgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Neuro-Oncology
|
June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo
Benjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Pediatric Blood & Cancer
|
August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)
Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis
Geert O Janssens, Marc H Jansen, Selmer J Lauwers, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Journal of Neuro-Oncology
|
July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation
Akifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
Nuclear Medicine Communications
|
January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
Sally L George, Nadia Falzone, Sarah Chittenden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 7, 2018
SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
Thankamma Ajithkumar, Gail Horan, Laetitia Padovani, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers
Georgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Neuro-Oncology
|
June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo
Benjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Pediatric Blood & Cancer
|
August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)
Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis
Geert O Janssens, Marc H Jansen, Selmer J Lauwers, et al.
Page
of 8